Paolo Caraceni

17PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - lipidsPolitical economy and social changeMedical virologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 11, 2026
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.

|Mar 19, 2026
Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.

Enrico Pompili, Giulia Iannone, Salvatore Piano

|Sep 04, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.

Alessandro Loglio, Ivan Gardini, Massimiliano Conforti

|Aug 16, 2024
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis.

Sebastián Marciano, Salvatore Piano, Virendra Singh

|Jun 27, 2024
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.

Enrico Pompili, Maurizio Baldassarre, Giulia Iannone

|Dec 12, 2023
Albumin in hospitalized patients with complications of cirrhosis: Not a suit for all seasons.

Enrico Pompili, Giacomo Zaccherini, Paolo Caraceni

Pageof 3

Frequent Collaborators

6 joint publications

Giacomo Zaccherini

6 joint publications

Maurizio Baldassarre

5 joint publications

Enrico Pompili

4 joint publications

Mauro Bernardi